UA93689C2 - Administration of dipeptidyl peptidase inhibitors - Google Patents
Administration of dipeptidyl peptidase inhibitorsInfo
- Publication number
- UA93689C2 UA93689C2 UAA200804056A UAA200804056A UA93689C2 UA 93689 C2 UA93689 C2 UA 93689C2 UA A200804056 A UAA200804056 A UA A200804056A UA A200804056 A UAA200804056 A UA A200804056A UA 93689 C2 UA93689 C2 UA 93689C2
- Authority
- UA
- Ukraine
- Prior art keywords
- administration
- dipeptidyl peptidase
- peptidase inhibitors
- pharmaceutical compositions
- well
- Prior art date
Links
- 102000003779 Dipeptidyl-peptidases and tripeptidyl-peptidases Human genes 0.000 title 1
- 108090000194 Dipeptidyl-peptidases and tripeptidyl-peptidases Proteins 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- IWYJYHUNXVAVAA-UHFFFAOYSA-N 2-[[6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]-4-fluorobenzonitrile Chemical compound C=1C(F)=CC=C(C#N)C=1CN1C(=O)N(C)C(=O)C=C1N1CCCC(N)C1 IWYJYHUNXVAVAA-UHFFFAOYSA-N 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Pharmaceutical compositions comprising 2-[6 (3-Amino-piperidin-l-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile and pharmaceutically acceptable salts thereof are provided as well as kits and articles of manufacture comprising the pharmaceutical compositions as well as methods of using the pharmaceutical compositions. The compositions may be used for the treatment of diabetes.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71756005P | 2005-09-14 | 2005-09-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA93689C2 true UA93689C2 (en) | 2011-03-10 |
Family
ID=50831057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200804056A UA93689C2 (en) | 2005-09-14 | 2006-09-13 | Administration of dipeptidyl peptidase inhibitors |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR109064A2 (en) |
| JO (1) | JO3254B1 (en) |
| UA (1) | UA93689C2 (en) |
-
2006
- 2006-09-13 UA UAA200804056A patent/UA93689C2/en unknown
- 2006-09-13 JO JOP/2006/0309A patent/JO3254B1/en active
-
2017
- 2017-07-14 AR ARP170101976A patent/AR109064A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JO3254B1 (en) | 2018-09-16 |
| AR109064A2 (en) | 2018-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY147393A (en) | Administration of dipeptidyl peptidase inhibitors | |
| MX2009002772A (en) | Administration of dipeptidyl peptidase inhibitors. | |
| UA101313C2 (en) | Normal;heading 1;heading 2;heading 3;WEEKLY ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS | |
| MY159522A (en) | Administration of dipeptidyl peptidase inhibitors | |
| IL184898A0 (en) | Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same | |
| LUC00011I1 (en) | ||
| IL181700A0 (en) | Quinazoline derivatives and pharmaceutical compositions containing the same | |
| MX2009006345A (en) | Compounds useful as protein kinase inhibitors. | |
| IL188942A0 (en) | Benzimidazole derivatives and pharmaceutical compositions containing the same | |
| IL179206A0 (en) | Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same | |
| WO2006133194A3 (en) | Methods for treating viral infection with oral or injectible drug solution | |
| UA93689C2 (en) | Administration of dipeptidyl peptidase inhibitors | |
| UA91717C2 (en) | Administration of 2-[[6-[(3r)-3-amino-l-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo- l(2h)-pyrimaidinyl]methyl]-benzonitrile for the treatment of conditions mediated with dipeptidyl peptidase inhibitors |